Huaren Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Net Income	-1,409	-1,368	188.06	180.78	130.4	94.62
Depreciation & Amortization	116.68	116.68	126.85	149.59	134.94	113.45
Other Amortization	10.25	10.25	8.55	11.02	16.45	16.94
Loss (Gain) From Sale of Assets	-0.02	-0.02	-4.35	-13.86	-0.11	-
Asset Writedown & Restructuring Costs	87.57	87.57	7.03	6.69	0.28	0.04
Loss (Gain) From Sale of Investments	-0.36	-0.36	-0.84	1.39	0.87	-0.71
Provision & Write-off of Bad Debts	9.86	9.86	-48.21	38.66	42.19	38.92
Other Operating Activities	1,424	1,412	130.73	75.7	111.27	24.02
Change in Accounts Receivable	172.59	172.59	9.02	135.83	-1,307	-345.47
Change in Inventory	9.11	9.11	-58.03	8.62	-2.18	-33.75
Change in Accounts Payable	-108.13	-108.13	-63.84	-361.01	303.49	81.32
Operating Cash Flow	293.6	322.36	305.6	217.98	-578.52	-10.74
Operating Cash Flow Growth	-25.47%	5.49%	40.19%	-	-	-
Capital Expenditures	-44.12	-24.69	-45.86	-42.33	-27.86	-57.96
Sale of Property, Plant & Equipment	0.02	0.03	10.03	26.43	0.07	-
Cash Acquisitions	-	-13.67	-61.61	-128	-431.8	-186.35
Divestitures	1.71	-	-	-	-	-
Investment in Securities	0.06	0.06	-	-	-	2.85
Other Investing Activities	0.36	0.36	0.3	0.09	1.01	3.49
Investing Cash Flow	-41.97	-37.92	-97.14	-143.81	-458.58	-237.97
Long-Term Debt Issued	-	843.33	1,498	2,010	1,995	360
Long-Term Debt Repaid	-	-1,129	-1,606	-2,179	-694	-202.7
Net Debt Issued (Repaid)	-134.14	-285.79	-108.26	-169.12	1,301	157.3
Common Dividends Paid	-46.32	-78.9	-86.15	-89.38	-71.38	-22.46
Other Financing Activities	-4.66	-4.82	73.69	105.84	-189.23	-22.49
Financing Cash Flow	-185.13	-369.5	-120.72	-152.67	1,040	112.35
Foreign Exchange Rate Adjustments	-0.24	0	-0	-0	-0.02	0.03
Net Cash Flow	66.26	-85.07	87.74	-78.5	3.03	-136.33
Free Cash Flow	249.48	297.67	259.74	175.65	-606.38	-68.71
Free Cash Flow Growth	-30.39%	14.60%	47.87%	-	-	-
Free Cash Flow Margin	19.87%	22.00%	15.87%	10.85%	-38.85%	-5.22%
Free Cash Flow Per Share	0.21	0.25	0.22	0.15	-0.51	-0.06
Cash Income Tax Paid	113.42	138.89	183.31	146.47	183.03	162.12
Levered Free Cash Flow	2,251	1,632	293.17	143.72	-634.17	-30.09
Unlevered Free Cash Flow	2,279	1,666	331.61	183.82	-594.71	-23.24
Change in Working Capital	55.04	55.04	-102.22	-231.97	-1,015	-298.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.